Hopen Life Science Fund II LP — Form D/A
Hopen Life Science Fund II LP of GRAND RAPIDS, MI, a pooled investment fund, filed a Form D amendment with the SEC on 2013-03-05. The offering totals $100.0M, of which $40.0M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2013-03-05
- Form: D/A
- Accession: 0001512497-13-000002
- Industry: Pooled Investment Fund
- Exemptions: 06, 3C, 3C.1
- Total offering: $100.0M
- Amount sold: $40.0M
- Remaining: $60.0M
- Minimum investment: $250K
- Investors: 19
- Date of first sale: 2011-01-17
- Security types: fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-174393
Issuer
- Name: Hopen Life Science Fund II LP
- CIK: 0001512497
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2010
- Address: 171 MONROE AVENUE NW, GRAND RAPIDS, MI, 49503
- Phone: (616) 325-2110
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Thomas Buschert | Executive Officer | Grand Rapids, MI |
| Gerald Callahan | Executive Officer | Kalamazoo, MI |
| Michael Fulton | Executive Officer | NOVI, MI |
| Mark Olesnavage | Executive Officer | Kalamazoo, MI |
Other filings by this issuer (1)
More